Not counted above: 5 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Amgen Inc. has been party to eleven Unified Patent Court cases, 5 times as claimant and 6 times as respondent. The most recent on record is UPC CFI 2220/2025 at the Munich Central Division, against Sanofi-Aventis Deutschland GmbH. Its most recent decision on the merits was in UPC CoA 529/2024 at the Court of Appeal on 25 November 2025: patent upheld as granted.